Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T13888 |
SLF
|
Others | Others |
SLF is a synthetic ligand for FK506-binding protein (FKBP)( with an affinity of 3.1 μM for FKBP51 and an IC50 of 0.22 μM for FKBP12). SLF can be used in the synthesis of PROTAC. | |||
T18061 |
KB02-SLF
|
Others | Others |
KB02-SLF is a PROTAC-based nuclear FKBP12 degrader, known as a molecular glue. It facilitates the degradation of nuclear FKBP12 by covalently modifying DCAF16, an E3 ligase. Moreover, KB02-SLF enhances the longevity of protein degradation in biological systems. The compound SLF acts as a linker, binding to the ubiquitin E3 ligase ligand KB02, resulting in the formation of KB02-SLF[1]. | |||
T13914 |
SLF-amido-C2-COOH
PROTAC FKBP12-binding moiety 1 |
Others | Others |
SLF-amido-C2-COOH is a synthetic ligand for FKBP (SLF), and can be used in the synthesis of PROTACs. | |||
T73817 | SLF TFA | ||
SLF TFA 是 FK506 结合蛋白 (FKBP) 的合成配体,对FKBP51的亲和力为 3.1 μM,对FKBP12的IC50为 2.6 μM,可用于合成PROTAC 分子。 | |||
T61112 |
SLF1081851
|
LPL Receptor | GPCR/G Protein |
SLF1081851 是一种 Spns2 抑制剂,抑制 S1P 释放 (IC50=1.93 μM)。SLF1081851 在发育和免疫系统中起关键作用。 | |||
T62851 |
SLF1081851 TFA
|
||
SLF1081851 (TFA) 是一种 Spns2 抑制剂,抑制 S1P 释放的 IC50 值为 1.93 μM。SLF1081851 (TFA) 在发育和免疫系统中发挥着关键作用。 | |||
T74026 |
AUTAC2
|
||
AUTAC2 是一种 FKBP12靶向自噬介导降解体 (AUTAC)。AUTAC2 包含一个 FBnG 和 SLF 部分,其中 SLF 与 FKBP12 非共价结合。 | |||
T39923 |
KB02-COOH
KB02-COOH |
||
KB02-COOH is a synthetic fragment derived from ubiquitin E3 ligase ligand KB02, which possesses potential utility in the synthesis of PROTAC compounds. Notably, KB02-COOH can be employed in the generation of PROTAC constructs like KB02-JQ1 and KB02-SLF. | |||
T18597 |
dFKBP-1
|
Others | Others |
dFKBP-1 is a potent and PROTAC-based FKBP12 degrader. dFKBP-1 incorporates the ligand SLF of FKBP12, the Thalidomide based cereblon ligand and a linker[1]. | |||
T80928 |
TSPO ligand-3
|
AUTACs | PROTAC |
TSPO ligand-3为AUTAC2的配体,其中AUTAC2包含p-氟苄基鸟嘌呤(FBnG)及FKBP合成配体(SLF)两部分,能在HeLa细胞中显著沉默FKBP12蛋白。 |